TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Biolabs AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
81,128
|
74,861
|
76,824 |
| Financial expenses |
82
|
121
|
27 |
| Earnings before taxes |
673
|
-1,930
|
-969 |
| EBITDA |
1,474
|
-975
|
21 |
| Total assets |
22,511
|
26,017
|
23,580 |
| Current assets |
20,956
|
24,289
|
21,066 |
| Current liabilities |
12,811
|
17,232
|
15,556 |
| Equity capital |
8,967
|
8,741
|
7,547 |
| - share capital |
1,559
|
1,612
|
1,604 |
| Employees (average) |
29
|
30
|
28 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
39.8%
|
33.6%
|
32.0% |
| Turnover per employee |
2,798
|
2,495
|
2,744 |
| Profit as a percentage of turnover |
0.8%
|
-2.6%
|
-1.3% |
| Return on assets (ROA) |
3.4%
|
-7.0%
|
-4.0% |
| Current ratio |
163.6%
|
141.0%
|
135.4% |
| Return on equity (ROE) |
7.5%
|
-22.1%
|
-12.8% |
| Change turnover |
8,743
|
-2,359
|
-1,944 |
| Change turnover % |
12%
|
-3%
|
-2% |
| Chg. No. of employees |
-1
|
2
|
3 |
| Chg. No. of employees % |
-3%
|
7%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.